Similar articles

• The promotion of gabapentin.

  Finucane TE. Finucane TE. Ann Intern Med. 2007 Feb 20;146(4):312-3; author reply 313-4. doi: 10.7326/0003-4819-146-4-200702200-00016. Ann Intern Med. 2007. PMID: 17310057 No abstract available.
• The promotion of gabapentin.

  Peterson ED, Boyce K, Overstreet K. Peterson ED, et al. Ann Intern Med. 2007 Feb 20;146(4):313; author reply 313-4. doi: 10.7326/0003-4819-146-4-200702200-00017. Ann Intern Med. 2007. PMID: 17310060 No abstract available.
• Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

  Steinman MA, Bero LA, Chren MM, Landefeld CS. Steinman MA, et al. Ann Intern Med. 2006 Aug 15;145(4):284-93. doi: 10.7326/0003-4819-145-4-200608150-00008. Ann Intern Med. 2006. PMID: 16908919 Review.
• Apparent discrepancy between published study of gabapentin treatment and internal company report.

  Mayo-Wilson E. Mayo-Wilson E. J Clin Psychiatry. 2013 Aug;74(8):853-4. doi: 10.4088/JCP.13lr08420. J Clin Psychiatry. 2013. PMID: 24021509 No abstract available.
• Gabapentin.

  Chadwick D. Chadwick D. Lancet. 1994 Jan 8;343(8889):89-91. doi: 10.1016/s0140-6736(94)90820-6. Lancet. 1994. PMID: 7903783 Review. No abstract available.